| Treatment group (%) |
|
| Induction only | 30 (26.1%) |
| Ongoing | 18 (15.6%) |
| Stopped | 53 (46.1%) |
| Finished | 14 (12.2%) |
| Maintenance cycles* |
|
| Median | 3 |
| Range | 1 - 7 |
| Reason for discontinuation (%) |
|
| Toxicity | 40 (75.5%) |
| Recurrence | 13 (24.5%) |
| Recurrence rate (%) | 37 |
| Induction only | 14 (38%) |
| Ongoing | 13 (35%) |
| Stopped | 9 (24%) |
| Finished | 1 (3%) |
| Time to recurrence (mo) |
|
| Median | 12 |
| Range | 3 - 66 |